Data as of Jul 30
| +0.08 / +0.28%|
The 8 analysts offering 12-month price forecasts for Sabra Health Care REIT Inc have a median target of 31.00, with a high estimate of 34.00 and a low estimate of 28.00. The median estimate represents a +9.35% increase from the last price of 28.35.
The current consensus among 9 polled investment analysts is to Buy stock in Sabra Health Care REIT Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.